These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2831750)

  • 1. Angiotensin converting enzyme inhibitors: animal experiments suggest a new pharmacological treatment for alcohol abuse in humans.
    Spinosa G; Perlanski E; Leenen FH; Stewart RB; Grupp LA
    Alcohol Clin Exp Res; 1988 Feb; 12(1):65-70. PubMed ID: 2831750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme inhibitors reduce alcohol consumption: some possible mechanisms and important conditions for its therapeutic use.
    Lingham T; Perlanski E; Grupp LA
    Alcohol Clin Exp Res; 1990 Feb; 14(1):92-9. PubMed ID: 2178480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of alcohol intake by a serotonin uptake inhibitor: evidence for mediation through the renin-angiotensin system.
    Grupp LA; Perlanski E; Stewart RB
    Pharmacol Biochem Behav; 1988 Aug; 30(4):823-7. PubMed ID: 2852370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
    Hirsch AT; Talsness CE; Smith AD; Schunkert H; Ingelfinger JR; Dzau VJ
    Circulation; 1992 Nov; 86(5):1566-74. PubMed ID: 1330361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of angiotensin II synthesis inhibition on alcohol consumption].
    Guivernau M; Pallavicini J
    Rev Med Chil; 2008 Aug; 136(8):968-75. PubMed ID: 18949179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of two angiotensin converting enzyme inhibitors in primary hypertension--a comparison of captopril and enalapril.
    Karlberg BE; Sjöstrand A; Ohman KP
    J Hypertens Suppl; 1986 Dec; 4(5):S432-4. PubMed ID: 3033182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
    Chan PS; Ronsberg MA; Cervoni P
    Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibitors and alcohol abuse.
    Riordan JF
    EXS; 1994; 71():323-31. PubMed ID: 8032163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH; Cody RJ
    Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498).
    Unger T; Moursi M; Ganten D; Hermann K; Lang RE
    J Cardiovasc Pharmacol; 1986; 8(2):276-85. PubMed ID: 2422465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the effects of angiotensin converting enzyme inhibitors with or without a thiol group in chronic renal failure in rats.
    Ohishi A; Suzuki H; Nakamoto H; Katsumata H; Sakaguchi H; Saruta T
    Clin Sci (Lond); 1989 Apr; 76(4):353-6. PubMed ID: 2540931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparison of captopril and enalapril in mild to moderate hypertension.
    Vlasses PH; Conner DP; Rotmensch HH; Fruncillo RJ; Danzeisen JR; Shepley KJ; Ferguson RK
    J Am Coll Cardiol; 1986 Mar; 7(3):651-60. PubMed ID: 3005384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats.
    Schiffrin EL; Gutkowska J; Thibault G; Genest J
    Can J Physiol Pharmacol; 1984 Jan; 62(1):116-23. PubMed ID: 6143602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibitors in congestive heart failure. Overview in comparison of captopril and enalapril.
    Levine TB; Olivari MT; Cohn JN
    Am J Med; 1986 Oct; 81(4C):36-9. PubMed ID: 3022583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
    Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
    Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalapril maleate versus captopril. A comparison of the hormonal and antihypertensive effects.
    Ayers CR; Baker KM; Weaver BA; Lehman MR
    Drugs; 1985; 30 Suppl 1():70-3. PubMed ID: 2994989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.